(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

RADIOFÁRMACOS

Em AnáliseInvention PatentPCT · AU2023050763

Application data

Invention Patent RADIOFÁRMACOS de ADVANCELL ISOTOPES PTY LIMITED — IPC A61K 33/241
Invention Patent RADIOFÁRMACOS de ADVANCELL ISOTOPES PTY LIMITED — IPC A61K 33/241. Drawing published by the INPI in the Industrial Property Gazette.

Number

112025002676

Type

Invention Patent

Filing

08/11/2023

Publication

07/29/2025

PCT

AU2023050763

Progress at the INPI

  1. Filing08/11/23
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 08/11/2023. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/29/2025. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

ADVANCELL ISOTOPES PTY LIMITED

AU

Inventors

K. K. (pessoa física)

AU

S. P. (pessoa física)

AU

W. T. (pessoa física)

AU

Technical data

Priority claims

AU

2022902273 · 08/11/2022

AU

2022902274 · 08/11/2022

Abstract

RADIOFÁRMACOS. Este pedido de patente se refere, geralmente, ao antígeno de membrana específico da próstata (PSMA) direcionado a compostos radiofarmacêuticos e seus usos em medicina nuclear para a imagem in vivo de vários tecidos e o tratamento e/ou prevenção de vários cânceres que expressam PSMA, especialmente câncer de próstata.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

07/29/2025

RPI 2847

Alteração de dados cadastrais

#1.1

02/18/2025

RPI 2824

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.